• Singapore Subsidiary Targets Asian Life Science Growth Markets
    The Ribbon cutting ceremony with Dr Thomas Keller, Senior Vice President Market Region Asia/Pacific/Africa at Eppendorf, Eva van Pelt, Co-Chairman of the Management Board of Eppendorf SE, and Lina Tao, Vice President Bioprocess Sales & Service at Eppendorf.

News & Views

Singapore Subsidiary Targets Asian Life Science Growth Markets

Aug 15 2022

New Eppendorf subsidiary features a high-tech laboratory for pipette calibration and offers an extensive range of high-quality laboratory services

The Eppendorf Group continues its growth track in Asia in a targeted manner and has opened a new site in Singapore. The new subsidiary is located in the heart of Singapore’s modern Biopolis science centre and offers attractive office workplaces for sales and service activities, a modern pipette calibration laboratory and a demo laboratory. Here high-quality laboratory services, which include extensive customer training and maintenance offerings, are provided.

"Asia, with the market regions China and Asia, Pacific, Africa (APA), is an extremely important market for the Eppendorf Group, already accounting for around one third of our total revenue," said Eva van Pelt, Co-CEO of Eppendorf SE. "Singapore is a centre of life sciences with a very large growth potential. We are therefore pleased to now be part of this dynamic life science ecosystem with our new location and to be able to further intensify and expand our existing customer relationships."

Eppendorf's new site is located within Singapore's Biopolis science centre, which focuses on biomedical research projects and enables close cooperation between public and private scientific institutions. In addition to modern office space, there is a service centre for all Eppendorf equipment, offering repairs, calibrations and validations, as well as a state-of-the-art calibration laboratory for pipettes. The additional purpose-built Bioprocess Center provides scientific and technical support to customers and partners throughout the Asia-Pacific region.

"From Singapore, we can now even better support our customers in scientific, research, healthcare, pharmaceutical and industrial sectors and offer them the relevant products and services within immediate reach," emphasised Eva van Pelt. "With this investment, we will be able to participate even better in the growth of the life science industry in Asia and continue our strategic approach for even more customer centricity in Asia."

This increased proximity to customers also includes the establishment of a modern and new central warehouse in Singapore. This will make the city-state the logistics hub for Southeast Asia with immediate effect, offering all customers in the region even faster and more reliable delivery.

More information online


Digital Edition

Lab Asia 29.6 Dec

December 2022

In This Edition Chromatography - Optimising Viral Vector Purification Strategies with Multimodal Chromatography - Key UHPLC Characteristics Required for High throughput LC-MS - New Low Volu...

View all digital editions

Events

Arab Health

Jan 30 2023 Dubai, UAE

Nano Tech 2023

Feb 01 2023 Tokyo, Japan

Medlab Middle East

Feb 06 2023 Dubai, UAE

FILTECH

Feb 14 2023 Cologne, Germany

View all events